CARVELĀ® DEBUTS THE FIRST-EVER SOFT SERVE DISPENSING BILLBOARD IN NYC

Kick off summer and enjoy a free serving of The Original Soft Serve™ Carvel®is kicking off the summer season like never before – with the first-ever soft serve dispensing billboard, because when temps rise, only The Original Soft Serve® will do. On Wednesday, June 18 in New York City's West Village, Carvel is serving up […]

CMP Announces International Career Pivot Day: A Global Celebration of Reinvention

DALLAS, TX / ACCESS Newswire / June 2, 2025 / Career Management Partners (CMP), a minority and woman owned talent and transition firm, believes no professional should feel trapped by a career rut or defined by a layoff. To shatter that stigma and reignite confidence, CMP proudly launches the inaugural International Career Pivot Day on

Michelob ULTRA and Designer Victor Solomon Merge Artistry With Legacy With New NBA Championship Bottles Infused with Recycled NBA Trophy Gold

The NBA's Official Global Beer Sponsor Celebrates the Finals with Limited-Edition Michelob ULTRA Bottle Design Featuring a Wearable Pendant, Diamonds and Real Gold Used in the Creation of NBA Trophies Michelob ULTRA, the no. 1 fastest-growing beer brand* and official global beer sponsor of the NBA, is bottling up that winning feeling with the debut

Clean-Seas West Virginia Receives First Shipment of Core Facility Equipment

LOS ANGELES, CA / ACCESS Newswire / June 2, 2025 / Clean Vision Corporation (OCTQB:CLNV) ("Clean Vision" or the "Company"), an emerging leader in innovative plastic conversion and clean fuel development, today marked the receipt of the first core technology components at its facility in Belle, West Virginia. Clean-Seas West Virginia, has begun construction of

Gladstone Alternative Income Fund Announces Increase in Monthly Cash Distribution for June 2025

MCLEAN, VA / ACCESS Newswire / June 2, 2025 / Gladstone Alternative Income Fund ("Gladstone Alternative" or the "Fund") announced today that its board of trustees declared monthly cash distributions to shareholders for the month of June, increasing the daily dividend rate by 1.149%, in comparison to the May dividend rate. The June distribution amount

Cube Launches D3: The First Agentic Analytics Platform Built on a Universal Semantic Layer

Cube, the leading provider of semantic layer technology for modern data stacks, today announced the launch of D3, the industry's first agentic analytics platform built on a universal semantic layer. D3 empowers data teams to scale productivity and enables business users to explore data independently-with governance, consistency, and trust built in. As data demands across

Steward Partners Strengthens its Western Presence, Expanding into Arizona with the Addition of Desert Sky Advisors

Scottsdale-based team brings $225 million to Steward Partners platform Steward Partners, a full-service, employee-owned, independent financial services firm, announces that Desert Sky Advisors – a private wealth advisory practice providing personalized, goals-based financial advice – has joined its platform, establishing the firm's first office in Arizona. https://mma.prnewswire.com/media/2380391/Steward_Partners_Logo.jpg The addition of Desert Sky Advisors, which has

Immuta Delivers Industry-First AI Capabilities to Accelerate Enterprise Data Provisioning

First-to-market features enable real-time, intelligent access decisions-eliminating manual reviews and accelerating data use across enterprises Immuta, the experts in data access and provisioning, today announced major updates to its Immuta AI layer. These new capabilities directly address a key challenge to enterprise AI adoption: slow, manual data access workflows that delay innovation and increase risk.

GV20 Therapeutics Presents Updated Phase 1 Monotherapy Data on GV20-0251 at the ASCO Annual Meeting 2025

GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, today announced that Dr. Kristopher Wentzel from the Angeles Clinic and Research Institute presented updated clinical and translational data of GV20-0251 monotherapy from the ongoing Phase 1/2 clinical trial evaluating GV20-0251 in patients with advanced solid tumors resistant to anti-PD(L)1 and other standard therapies (NCT05669430) at the

Phenomenex Launches Cutting-Edge 0.15 mm ID Micro LC Columns and Traps for Precision Low-Flow Applications

Ensures Increased Durability and Versatility for High-sensitivity Biomarker Analysis Phenomenex Inc., a Danaher Company, a global leader in the research and manufacture of advanced technologies for the separation sciences, has announced the expansion of its product portfolio at ASMS with the introduction of 0.15 mm ID Micro LC Columns and Micro Traps, specifically designed for

Scroll to Top